Next Article in Journal
Cancer Epigenetic Biomarkers
Next Article in Special Issue
Perspectives and Concerns on Late Effects Regarding Sexuality among Adolescents and Young Adults Treated for Testicular Germ Cell Tumor: The PRICELESS-Study—A Qualitative Study
Previous Article in Journal
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression
Previous Article in Special Issue
Dietary Intake of Anthocyanidins and Renal Cancer Risk: A Prospective Study
 
 
Article
Peer-Review Record

The Prognostic Role of Body Mass Index on Oncological Outcomes of Upper Tract Urothelial Carcinoma

Cancers 2023, 15(22), 5364; https://doi.org/10.3390/cancers15225364
by Kang Liu 1, Hongda Zhao 1, Chi-Fai Ng 1, Jeremy Yuen-Chun Teoh 1,*, Pilar Laguna 2, Paolo Gontero 3, Iliya Saltirov 4 and Jean de la Rosette 2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2023, 15(22), 5364; https://doi.org/10.3390/cancers15225364
Submission received: 9 October 2023 / Revised: 26 October 2023 / Accepted: 7 November 2023 / Published: 10 November 2023
(This article belongs to the Special Issue Urological Cancer: Epidemiology, Prevention and Quality of Life)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

In this study, authors have compared survival outcomes by BMI in patients with UTUC. 

They found that patients with higher BMI presented a lower rate of recurrence.

I have some points that require further clarification.

 

In general

-BMI is not a direct measure of obesity and other methodologies such as bioimpedance would be more appropriate such as CT scan or bioimpedance. 

-It is not the same a patient with BMI 25 than other with BMI 40, a stratified analysis would be required ( I do not know if possible due to sample size)

 

Abstract

chrematistics? do you mean characteristics?

A more detailed information on the dataset would be helpful for understanding the sample. For example

In table 1, age, smoking status do not sum 862 example (277+250+237) The same in overweight group and total in many categories.  Maybe the authors are not including not available data. Please check.

 

The same in table 2 with occupational hazard, family history, tumor size, and others. Maybe the authors are not including not available data. Please check.

What is the median follow-up? 

Was follow-up standarized among centers? How was it performed?

Kaplan Meier curves should have number at risk patients.

Please add the HR values?

How RFS was calculated? local recurrence at the kidney fossa? In the remaining part in case of KSS? bladder recurrence? 

 

In limitation paragraph state

Second, there can be missing data in our cohort that could be compensated for by the considerable sample size. 

-In which variables there is missing data?

Comments on the Quality of English Language

Abstract

chrematistics? do you mean characteristics?

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Abstract; Background  „Whether overweight and obese upper urinary tract carcinoma (UTUC) patients have better or worse survival outcomes remain controversial.”   Please write the full sentence, for example: “Aim of this study was to evaluate whather…..”

Statistical analyses: what is with patients with BMI <18.5; were they excluded?

Is detailed data on BMI available? I ≥25.0 is too bride term; this should be classified in overweight (25-29), obese (30-34.9), severe obese (>=35), for example.

Figure are very small; readers must strongly increase the page size to see them. Please modify.

Authors should conduct Cox regression analyses (even univariable, not necessary multivariable as cohorts were well matched) to show the Hazard Ratios for BMI.  This would strengthen the study results and conclusions.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

Thank you for responses

Back to TopTop